Clearside Biomedical, Inc. logo

Clearside Biomedical, Inc.

Revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®)

39 employees · est. 2012

VS
KriyaBio SA logo

KriyaBio SA

Enabling topical ocular administration of biologics

2 employees · est. 2020 · Geneva, Switzerland

Clearside Biomedical, Inc. is the older company (2012 vs 2020); Clearside Biomedical, Inc. is the larger of the two.

Side-by-Side Comparison

Clearside Biomedical, Inc. KriyaBio SA
Founded
2012 older 2020
Headquarters
Not tracked yet Geneva, Switzerland
Employees
39 larger 2
Industry
Biotechnology, Health Care, Health and Wellness Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Post Ipo Equity Non Equity Assistance
Total Funding
$203.90M Not tracked yet
Funding Rounds
8 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Ophthalmic Company, Biopharmaceutical, Ocular Microinjection Platform, Retinal Disease, Uveitis, Diabetic Macular Edema, Wet-AMD, Suprachoroidal Space, Therapeutic Products, Ophthalmology, Microinjector Technology, Drug Delivery, Non-surgical Procedure, Atlanta, Georgia, CLS1001 Drug Delivery, Permeation Enhancement Technology, Permeation Enhancers, Bioavailability, Ocular Drug Delivery, Topical Drug Delivery, Ophthalmic Drug Formulations, Biologics, AMD Treatment, Health Care Costs, Patient Safety, Patient Compliance, Needleless Delivery, Non-invasive Drug Delivery, Age-related Macular Degeneration
Website
clearsidebio.com kriyabio.com
Clearside Biomedical, Inc. logo

About Clearside Biomedical, Inc.

Clearside Biomedical, Inc. is a biopharmaceutical company that is revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®). The company's proprietary SCS Microinjector® enables a non-surgical procedure for the targeted and compartmentalized delivery of...

KriyaBio SA logo

About KriyaBio SA

KriyaBio is a biotech startup founded in 2020, headquartered in Switzerland. The company focuses on enabling topical ocular administration of biologics through its innovative drug delivery solutions built around the proprietary permeation enhancer KB01. This technology has the potential to revolutio...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Clearside Biomedical, Inc. and KriyaBio SA — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Clearside Biomedical,... and KriyaBio SA — by email.

Frequently Asked Questions

Clearside Biomedical, Inc. — Revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®). KriyaBio SA — Enabling topical ocular administration of biologics . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Clearside Biomedical, Inc. has raised $203.90M while KriyaBio SA has raised undisclosed funding.
Clearside Biomedical, Inc. and KriyaBio SA operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Clearside Biomedical, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy